The introduction of biologic agents, especially rituximab (RTX), a chimeric monoclonal antibody targeting CD20+ B cells, has revolutionized the treatment landscape. This review synthesized the current ...
Treatment options for PPMS are limited and often fail to slow disability progression. Both Ocrevus and rituximab are designed to promote the death of B-cells, the immune cells that produce the ...
Although ibogaine gained popularity in the U.S. and Europe in the 1980s as a non-addictive treatment for drug dependency, it’s still classified as a Schedule I substance under the Controlled ...
Gum disease is a common issue for many adults, possibly causing red or bleeding gums. Treatment may involve cleaning bacteria from under the gums and maintaining good dental hygiene at home.
Researchers found that the most common first-line treatment regimen was fludarabine, cyclophosphamide, and rituximab. The use of targeted therapies for chronic lymphocytic leukemia (CLL ...